What does Dr Philippe Debruyne do?

Dr Philippe Debruyne is a specialist medical practice in Tervuren. Private Limited, started on 26 March 2007, 1 establishment.

What is the address of Dr Philippe Debruyne?

The registered office of Dr Philippe Debruyne is located at Ringlaan 66, 3080 Tervuren.

Is Dr Philippe Debruyne still active?

Yes. According to the CBE (2 November 2026) Dr Philippe Debruyne is active, legal situation “Normale toestand”, started on 26 March 2007.

Is Dr Philippe Debruyne registered on Peppol?

No, Dr Philippe Debruyne is currently not registered on the Peppol network.

What is the enterprise number of Dr Philippe Debruyne?

The enterprise number of Dr Philippe Debruyne is BE0888431809.

When was Dr Philippe Debruyne founded?

Dr Philippe Debruyne was founded on 26 March 2007.

Is Dr Philippe Debruyne a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 26 March 2007; 5 annual accounts filed, latest fiscal year 2025.

How much profit did Dr Philippe Debruyne make in 2025?

Dr Philippe Debruyne posted a profit after taxes of € 406,779 in financial year 2025.

What is the revenue of Dr Philippe Debruyne?

In its most recent annual accounts (2025), Dr Philippe Debruyne reported revenue of € 851,103.

How many employees does Dr Philippe Debruyne have?

According to the 2025 annual accounts, Dr Philippe Debruyne has 0.7 full-time equivalents (FTE).

Dr Philippe Debruyne (Private Limited) - Tervuren

Dossier Dr Philippe Debruyne, printed on 2 November 2026 from databakkes.be/en/0888431809/dr-philippe-debruyne. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

Dr Philippe Debruyne from Tervuren, company number BE0888431809, closed financial year 2025 with a result of € 406,779 after tax. For that financial year Dr Philippe Debruyne recorded revenue of € 851,103 and equity of € 1.6 million. Compared with financial year 2024, the result moved from € 306,846 to € 406,779. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 30, 2026.

What it is worth Healthy

€ 1.6 million

▼ 12% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 406,779

▲ 33% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 83,238

▲ 37% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 640,825 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents

0.7

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 36,386

▼ 2% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 14,366

▼ 11% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 25,000

▼ 50% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 13,291

▲ 67% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 32,672

▼ 65% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Revenue	€ 651,865 Revenue 2022: € 651,865 First fiscal year in the series	€ 775,332 Revenue 2023: € 775,332 ▲ 19% vs 2022 (€ 651,865) Favourable step	€ 728,455 Revenue 2024: € 728,455 ▼ 6% vs 2023 (€ 775,332) Unfavourable step	€ 851,103 Revenue 2025: € 851,103 ▲ 17% vs 2024 (€ 728,455) Favourable step	▲ 17%
Gross margin	€ 389,764 Gross margin 2022: € 389,764 First fiscal year in the series	€ 471,425 Gross margin 2023: € 471,425 ▲ 21% vs 2022 (€ 389,764) Favourable step	€ 442,321 Gross margin 2024: € 442,321 ▼ 6% vs 2023 (€ 471,425) Unfavourable step	€ 583,823 Gross margin 2025: € 583,823 ▲ 32% vs 2024 (€ 442,321) Favourable step	▲ 32%
Profit after taxes	€ 282,188 Profit after taxes 2022: € 282,188 First fiscal year in the series	€ 332,263 Profit after taxes 2023: € 332,263 ▲ 18% vs 2022 (€ 282,188) Favourable step	€ 306,846 Profit after taxes 2024: € 306,846 ▼ 8% vs 2023 (€ 332,263) Unfavourable step	€ 406,779 Profit after taxes 2025: € 406,779 ▲ 33% vs 2024 (€ 306,846) Favourable step	▲ 33%
Equity	€ 1,614,152 Equity 2022: € 1,614,152 First fiscal year in the series	€ 1,788,141 Equity 2023: € 1,788,141 ▲ 11% vs 2022 (€ 1,614,152) Favourable step	€ 1,882,419 Equity 2024: € 1,882,419 ▲ 5% vs 2023 (€ 1,788,141) Favourable step	€ 1,648,374 Equity 2025: € 1,648,374 ▼ 12% vs 2024 (€ 1,882,419) Unfavourable step	▼ 12%
Total debts	€ 183,057 Total debts 2022: € 183,057 First fiscal year in the series	€ 168,518 Total debts 2023: € 168,518 ▼ 8% vs 2022 (€ 183,057) Favourable step	€ 162,666 Total debts 2024: € 162,666 ▼ 3% vs 2023 (€ 168,518) Favourable step	€ 84,863 Total debts 2025: € 84,863 ▼ 48% vs 2024 (€ 162,666) Favourable step	▼ 48%
Cash	€ 35,760 Cash 2022: € 35,760 First fiscal year in the series	€ 114,922 Cash 2023: € 114,922 ▲ 221% vs 2022 (€ 35,760) Favourable step	€ 60,758 Cash 2024: € 60,758 ▼ 47% vs 2023 (€ 114,922) Unfavourable step	€ 83,238 Cash 2025: € 83,238 ▲ 37% vs 2024 (€ 60,758) Favourable step	▲ 37%
Retained profit	€ 1,595,552 Retained profit 2022: € 1,595,552 First fiscal year in the series	€ 1,769,541 Retained profit 2023: € 1,769,541 ▲ 11% vs 2022 (€ 1,595,552) Favourable step	€ 1,863,819 Retained profit 2024: € 1,863,819 ▲ 5% vs 2023 (€ 1,769,541) Favourable step	€ 1,629,774 Retained profit 2025: € 1,629,774 ▼ 13% vs 2024 (€ 1,863,819) Unfavourable step	▼ 13%
Dividend	€ 230,000 Dividend 2022: € 230,000 First fiscal year in the series	€ 158,274 Dividend 2023: € 158,274 ▼ 31% vs 2022 (€ 230,000) Unchanged	€ 212,568 Dividend 2024: € 212,568 ▲ 34% vs 2023 (€ 158,274) Unchanged	€ 640,825 Dividend 2025: € 640,825 ▲ 201% vs 2024 (€ 212,568) Unchanged	▲ 201%
Bank debt	€ 100,000 Bank debt 2022: € 100,000 First fiscal year in the series	€ 75,000 Bank debt 2023: € 75,000 ▼ 25% vs 2022 (€ 100,000) Favourable step	€ 50,000 Bank debt 2024: € 50,000 ▼ 33% vs 2023 (€ 75,000) Favourable step	€ 25,000 Bank debt 2025: € 25,000 ▼ 50% vs 2024 (€ 50,000) Favourable step	▼ 50%
Balance sheet total	€ 1,797,209 Balance sheet total 2022: € 1,797,209 First fiscal year in the series	€ 1,956,658 Balance sheet total 2023: € 1,956,658 ▲ 9% vs 2022 (€ 1,797,209) Unchanged	€ 2,045,085 Balance sheet total 2024: € 2,045,085 ▲ 5% vs 2023 (€ 1,956,658) Unchanged	€ 1,733,237 Balance sheet total 2025: € 1,733,237 ▼ 15% vs 2024 (€ 2,045,085) Unchanged	▼ 15%
Employees (FTE)	-	0.7 Employees (FTE) 2023: 0.7 First fiscal year in the series	0.7 Employees (FTE) 2024: 0.7 Unchanged (0.7) Unchanged	0.7 Employees (FTE) 2025: 0.7 Unchanged (0.7) Unchanged

Key figures of Dr Philippe Debruyne, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr Philippe Debruyne?

What happened at Dr Philippe Debruyne in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 30, 2026 New annual accounts for financial year 2025: profit of € 406,779 (▲ 33% vs 2024). filed late Source: NBB ↗
Jul 24, 2007 New establishment in Tervuren. KBO
Mar 26, 2007 Start of the company according to the CBE. KBO

In short

From € 282,188 profit in 2022 to € 406,779 profit in 2025.

Paid € 604,861 in corporate taxes since 2022.

Best year ever: 2025, with € 406,779 profit.

Paid out € 1.2 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

Establishments

Establishment units

Physical locations of this company

Registered office

Ringlaan 66

3080 Tervuren

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

Cardimel

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0888.431.809

VAT number

BE 0888.431.809

Registered office

Ringlaan 66, 3080 Tervuren

Names & denominations

Dr Philippe Debruyne

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

26 March 2007

Peppol

Not registered

Activities · NACE

Activiteiten van medisch specialisten

Medische praktijken

View on CBE Public ↗ Annual accounts (NBB) ↗